Market News
Market news
-
News Baxter completes acquisition of Claris Injectables, expanding generic injectable medicines portfolio
Baxter plans to invest in further increasing Claris Injectables’ capacity and capabilities, including adding new aseptic manufacturing and lyophilization. -
News TraceLink expands offering with ROC IT Solutions acquisition
Company can now offer solutions for serialized receiving, picking, shipping, returns, deactivation, aggregation, de-aggregation, label printing and tag management of pharmaceutical products. -
News Cherwell publishes Cleanroom Decontamination Guide
Guide aims to help the operator understand the complex protocols and heavily regulated procedures associated with pharmaceutical cleanrooms. -
News STA Pharmaceutical merges with WuXi¹s Pharmaceutical Development Services Division
The merger enables STA to advance NCEs from pre-clinical stage to New Drug Application and to market faster and more efficiently for pharma and biotech customers. -
News BMS and Clovis Oncology announce a broad clinical collaboration to evaluate combination of Opdivo and Rubraca
Pivotal Phase III trials planned for 2017 will evaluate Rubraca + Opdivo, Rubraca as monotherapy, and Opdivo as monotherapy in first line maintenance treatment for advanced ovarian and advanced triple-negative breast cancers. -
News Arch Biopartners' GMP manufacturing of AB569 on schedule
Dalton Pharma Services is preparing glass vials in three varying dose formulations for the clinical kits needed to support the Phase I safety trial for AB569 at the CVAMC later this year. -
News AstraZeneca and Merck establish oncology collaboration
Collaboration aims to maximize the potential of PARP and MEK inhibitors in combination with PD-L1/PD-1 medicines, based on growing scientific evidence that these combinations offer new potential for the treatment of a range of tumor types. -
News Torbay Pharmaceuticals opens new £26 million pharmaceutical manufacturing unit
The new facilities enable to company to further grow and flourish. -
News Pall introduces proprietary bioreactor control system
The mPath bioreactor control system is the first to be developed and delivered by a technology supplier specifically for their product line, allowing full access to bioreactor capabilities that current commercial solutions cannot provide. -
News CPHI Annual Reports - how accurate were they 5 years on?
The CPHI predictions foresaw advancement in QbD, continuous processing, and a dramatic rise in FDA warning letters. -
News Bavarian Nordic and Janssen to develop vaccine regimens against HIV-1 and Hepatitis B
Deal builds on ongoing collaboration to develop vaccines for Human Papillomavirus (HPV) and Ebola. -
News Valeant launches Siliq Injection in US
Dermatology unit is rebranded Ortho Dermatologics. -
News Lonza innovation to transform biological development and manufacturing
Company launches Ibex innovation in biological development and manufacturing. -
News New leakproof vials offer enhanced sample and user safety
Thermo's Samco Clicktainer vials provide secure and reliable sample collection and transport. -
News Mylan receives WHO Prequalification for generic Sovaldi
First generic prequalification for sofosbuvir tablets. -
News BMS's Orencia receives second EC approval in less than a year
New approval for treatment of active psoriatic arthritis (PsA). -
News Vertex and Concert Pharmaceuticals complete asset purchase agreement for CTP-656
Vertex now has worldwide development and commercialization rights to CTP-656 and other assets related to the treatment of cystic fibrosis. -
News Artificial intelligence to discover drugs in a multi-year multimillion dollar deal
AI thought to have massive potential to reduce the cost associated with the discovery of new drugs. -
News New research highlights lack of confidence in serialization preparations
40% of industry professionals admit they are not clear about the global requirements for serialization. -
News STA signs 5-year supply agreement with TESARO
STA will provide supplies of certain starting and intermediate materials for the recently launched Zejula. -
News Merck launches Remicade biosimilar for all eligible indications, in the US
The biosimilar's list price will represent a 35% discount to the current list price of Remicade. -
News Lilly backs Nektar Therapeutics' novel immunological therapy
NKTR-358 has the potential to treat a number of autoimmune and other chronic inflammatory conditions. -
News GSK receives FDA approval for a new self-injectable formulation of Benlysta
The approval marks the first subcutaneous self-injection treatment option for patients with systemic lupus erythematosus. -
News Boehringer Ingelheim breaks ground on $217 million expansion of Fremont, California manufacturing facility
Expansion will triple capacity, add nearly 300 new jobs. -
News Merck and Pfizer collaborate with Corning to modernize pharmaceutical glass packaging
Collaborations result in development of Corning Valor Glass. -
News Recipharm and LIDDS establish industrial manufacturing capabilities for a novel prostate cancer product
GMP Manufacturing line industrialised according to a unique process invented by LIDDS, involving the installation of novel equipment that is new to the pharmaceutical industry. -
News Catalent and academia on quest to better understand pediatric drug formulation and delivery challenges
Goal of the collaboration is to identify therapies and diseases for which there is a high need for pediatric-friendly formulations. -
News LifeArc negotiates exclusive licence deal with Nemysis for oral iron supplement technology
IHAT, a novel synthetic material, is a commercially viable alternative to ferrous salts for iron supplementation. -
News Onyx helps to accelerate TopiVert’s compounds to clinic
With support from the CRO, TopiVert has been able to accelerate scale-up and produce GMP batches, which are now being used in clinical trials. -
News GSK delivers double-edged sword
Company announces investments, the sale of several products and a proposal to close a UK manufacturing site. -
News South Korean pharma rapidly becoming manufacturing export hub
Overseas buyers at CPHI Korea double in the past 2 years. -
News Transfer technology expert expands US presence following multi-million-pound investment
Investment follows demand for the company's AseptiSafe and PharmaSafe product ranges, which transfer APIs in small- and large-scale pharmaceutical manufacturing environments. -
News FDA approves new treatment to reduce the risk of breast cancer returning
Nerlynx is the first extended adjuvant therapy for patients with HER2-positive breast cancer. -
News Shire expands broad monoclonal antibody research platform
Shire obtains worldwide license to pursue development and commercialization of a novel, potentially differentiated, pre-clinical bi-specific antibody candidate for Hemophilia A. -
News Technology adoption fuels growth for pharma tech firm
Company has experienced double digit growth across its automation, MES and managed services offering. -
News Catalent launches new OptiForm Solution Suite
The service offers quick and efficient path from late-stage discovery to Phase I clinical trials. -
News FDA approves Impax's AB rated generic Concerta Extended-Release Tablets CII
Company expects to launch by the end of the year. -
News GSK ships 2017-18 seasonal influenza vaccines for US market
Company expects to supply up to 40 million doses across both vaccines for the US market in the 2017-18 season. -
News Bosch sets standards in sterile powder filling with AFG 5000
The system's new, variable transport system avoids bottlesnecks or delays in workflow. -
News Merck KGaA refines Western European life science production site network
Company to invest €90 million and cut 200 jobs. -
News SMC says ‘yes’ to Opdivo for blood cancer patients
Patients in Scotland will now join those in England and Wales and be able to benefit from this potentially life-extending immunotherapy on the NHS. -
News Sanofi to acquire Protein Sciences
Acquisition adds recombinant-based influenza vaccine to Sanofi Pasteur's portfolio. -
News Agilent Technologies acquires Raman spectroscopy innovator, Cobalt Light Systems
Cobalt's portfolio of solutions accelerates entry into high-growth Raman spectroscopy market and expands Agilent’s value proposition for pharmaceutical and biopharma customers. -
News CPHI Worldwide opens entries for largest ever Pharma Awards
The 2017 awards include eight new categories - celebrating outstanding achievements in the pharma industry. -
News Disappointment for Scottish patients with PAH as SMC says ‘no’ to Uptravi
Selexipag is an innovative, oral treatment that specifically targets the prostacyclin pathway. -
News Information sharing - the most valuable benefit expected from serialization?
NEXUS 17 attendees claim the greatest serialization challenge thus far has been line vendors’ inability to deliver a solution on time and within scope. -
News UK Supreme Court rules in Lilly's favour on Alimta vitamin regimen patents
Actavis's products directly infringe Lilly's vitamin regimen patents in the UK, France, Italy and Spain. -
News ChargePoint Technology invests in production capabilities for large-scale containment valves
The new 5-axis machine will speed up the production and delivery of larger diameter valves up to 350 mm. -
News I Holland Presents Interphex Japan with its innovative tooling solutions
IH-TMS Tool Management System and the company's latest tool coating solutions interest exhibition visitors. -
News Lonza completes acquisition of Capsugel
Acquisition create leading integrated solutions provider to the global pharma and consumer healthcare industries. -
News Impax launches additional strengths of generic Focalin XR extended-release capsules CII
Company has immediately initiated commercialization activities. -
News Novartis receives EU approval for Cosentyx label update
Label update includes 52 week data from CLEAR study demonstrating long-term superiority of Cosentyx versus Stelara in psoriasis. -
News Specialist CRO expands pharmacovigilance capabilities
Pharma clients now have direct and immediate access to a fully compliant safety database without needing to invest in their own system or use an interim solution to ensure compliance. -
News New design for nutrients - Doppelherz sparkles with effervescent IML packaging from Sanner
Brilliance tubes provide a user-friendly and attractive all-in-one solution. -
News BIOCAD’s rituximab biosimilar to receive MA in India
First shipment of BIOCAD’s Acellbia to India is scheduled for September 2017. -
News Sun Pharma & Samsung BioLogics announce strategic manufacturing tie-up for Tildrakizumab
Tildrakizumab is an investigational IL-23p19 inhibitor being evaluated for the treatment of moderate to severe plaque psoriasis. -
News Idifarma approved for EU-GMP commercial capsule manufacturing
Idifarma, a Spanish CDMO, has expanded its GMP manufacturing offering with the installation of new automatic capsule filling capabilities at its EU-GMP approved plant in Pamplona, Spain. -
News Lilly's Olumiant gets the thumbs up in Japan for the treatment of rheumatoid arthritis
In clinical studies, baricitinib has demonstrated significant improvement in the signs and symptoms of RA compared to standard-of-care therapies. -
News New second generation solvent evaporators from Biotage
Three new TurboVap evaporation systems increase laboratory reliability. -
News Gyros Protein Technologies introduces new ADA solution for immunogenicity market
Developed to support assay development and validation for detection of anti-drug antibodies. -
News Exscientia enters strategic drug discovery collaboration with GSK
Pre-clinical collaboration focused on up to 10 targets nominated by GSK. -
News Patheon to invest $45 million, expanding capabilities to support continued growth
Investments in commercial and development spray drying, and flexible manufacturing solutions. -
News Bioverativ completes acquisition of True North Therapeutics
Strengthens leadership in rare blood disorders with first-in-class candidate to treat cold agglutinin disease, a chronic autoimmune hemolytic anemia with no approved therapies. -
News First prostate cancer patients treated with Augmenix's SpaceOAR Hydrogel in Israel
The Chaim Sheba Medical Center now offers the hydrogel spacer to reduce side-effects during prostate cancer radiation therapy. -
News Copley Scientific releases upgraded SPU 2000 for reduced inhaler testing variability
Company's modification makes the SPU 2000 a more cost effective laboratory tool. -
News BASF plans significant investment in ibuprofen capacities in Germany and North America
New world-scale ibuprofen production plant in Ludwigshafen; additional capacity expansion of ibuprofen plant in Bishop, Texas. -
News UK availability of Rixathon and Erelzi paves way for NHS savings
Two new biosimilar medicines available to treat patients with specific blood cancers and a range of inflammatory condition. -
News Vectura enters new development and licence agreement for a US inhaled generic
Agreement concerns an existing inhaled combination therapy for asthma and COPD delivered using a pMDI. -
News LifeArc, Dstl and CDRD collaborate to identify antibacterial drug targets
Novel approach capitalises on commonality across pathogens. -
News Allergan introduces REFRESH OPTIVE MEGA-3 enhanced with flaxseed oil
New offering restores lipid layer and brings hydration to all three layers of tear film damaged by Dry Eye. -
News Bioconjugation specialist Innova Biosciences acquired by SYGNIS
Innova’s range of antibody and protein labeling products and services ideally complements SYGNIS’ customer base and existing genomics and proteomics portfolio. -
News QS Pharma receives approval from EMA for commercial manufacture
The CDMO is now approved to manufacture medicinal products for the US, Europe and Japan. -
News Technology selection identified as biggest hurdle in serialization race for compliance
Resourcing the deployment of serialization systems and processes also cited as a significant barrier to compliance with European FMD, -
News Hikma Pharmaceuticals makes leadership and organisational changes to US business
US business will be organized into two entities - a US Generics Division and a US Injectables Division. -
News Takeda and Biological E. partner to develop low-cost combination vaccines for low- and middle-Income countries around the globe
Two recently-signed agreements will transfer Takeda’s measles and acellular pertussis vaccine technologies to India-based multi-national company Biological E. Limited to develop low-cost combination vaccines including diphtheria, tetanus and acellular ... -
News Juniper Pharma Services brings PSD-1 spray dryer online
The addition enables the CDMO to scale-up early-phase bench top processes to support later stage clinical development and niche, low volume manufacturing requirements. -
News Arcinova investment reduces R&D and manufacturing time by more than a month
Arcinova has invested in a Uniqsis FlowSyn continuous flow reactor enabling them to develop and simplify the scale-up of a challenging API batch process. -
News Accelerating freeze drying cycle development with just seven vials
Compared with other small-scale R&D freeze dryers, the LyoCapsule lyophilizer is the only system that can monitor and independently control the wall temperature via use of the center vial product temperature. -
News Takeda completes new manufacturing facilities at the Oranienburg site in Germany
The manufacture of solid dosage form pharmaceutical products would be transferred from the Osaka Plant to the new plant. -
News QuVa Pharma announces availability of sodium bicarbonate syringe
Compounded Sodium Bicarbonate PF 8.4% 50mEq per syringe is expected to help alleviate chronic drug shortage impacting the nation's hospitals. -
News Glenmark Pharmaceuticals licenses small molecule oncology compound from APC Therapeutics to expand IO portfolio
The compound has the potential to be used as a monotherapy or in combination with approved therapies to address unmet needs in cancer treatment. -
News Merck Ventures creates new immuno-oncology company iOnctura
iOnctura is set up to develop a pipeline of assets targeting immunosuppression in the tumour microenvironment. -
News J&J completes acquisition of Actelion
Actelion will now become part of the Janssen Pharmaceutical Companies of J&J. -
News Sandoz receives approval in Europe for Rixathon to treat blood cancers and immunological diseases
Sandoz now has four biosimilars approved in Europe - more than any other company. -
News BMS to sell manufacturing facility in Swords, Ireland to SK Biotek
Company shifts manufacturing focus in Ireland to reflect growing biologics portfolio with ongoing investment in Cruiserath biologics facility. -
News FlyPharma Conference: "Collaboration is the Key"
Delegates at the recent FlyPharma Conference pick out collaboration as their main goal for the coming year. -
News Parexel and Sanofi collaborate to advance the use of wearable devices in life science industry
Preliminary findings from pilot study validate use of wearable technologies to collect data and manage clinical trials more effectively and efficiently. -
News LifeArc, previously MRC Technology, set to transform the medical research landscape
Investment will focus on new innovations in therapeutics for neurodegeneration, antibiotic resistance, cancer and respiratory diseases. -
News FDA accepts Sandoz regulatory submission for a generic version of Advair Diskus
Sandoz believes its combination product will offer asthma and COPD patients same safety and efficacy as reference medicine. -
News TraceLink expands European HQ to accommodate projected 207% EU employee growth in 2017
Extends EMEA sales team with addition of two new regional sales leaders in DACH and Southern Europe regions. -
News Orthogonal platform enhances protein separation and characterisation
Enables labs around the world to generate more useful information from complex proteins, antibodies, polypeptides and polysaccharides. -
News Irvine Scientific adds new Center of Excellence for R&D
Company adds fifth building in Southern California. -
News Biogen announces management change
Company's CFO leaves to join another biopharma company. -
News SGS expands extractables and leachables testing capabilities at it Shangahi facility
Investment allows company to increase its capacity to handle E&L projects for applications including container testing, medical device evaluation and testing equipment used in pharmaceutical production. -
News SGS successfully implements Oracle Argus solution for drug safety and regulatory compliance
Argus improves the quality and timeliness of safety case processing and reporting, and reduces operational risks for both clinical trial and post-marketed pharmacovigilance data. -
News Major boost for combatting drug addiction in Scotland as SMC gives green light to new wafer-thin treatment
Espranor represents the first major advance available in opioid substitution therapy for 10 years. -
News TraceLink unveils industry’s first Compliance and Digital Information Platform for pharmacies with EU FMD requirements
Application "addresses a critical information gap that has existed for decades between pharmaceutical companies, pharmacists and patients." -
News FDA requests removal of certain prescription opioid for risks related to abuse
Injection abuse of reformulated Opana ER has been associated with a serious outbreak of HIV and hepatit.is C -
News Aptar Pharma extends its child-resistant nasal pump manufacturing capabilities in North America
As of today, all major brands of nasal decongestant topical sprays in the US come with Aptar Pharma’s child-resistant feature. -
News Lubrizol invests $60 million to expand Particle Sciences, Vesta and other facilities
Investments will strengthen the excipients, polymers, drug formulation and manufacturing, and medical device contract manufacturing capabilities throughout the company's global facilities. -
News Valeant sells iNova Pharmaceuticals for $930 million
Selling iNova part of Valeant's efforts to simplify and strengthen its balance sheet. -
News Lilly announces strategic collaboration with KeyBioscience
Collaboration to focus on a potential new class of treatments for metabolic disorders. -
News Merck's SOLu-Trypsin enzyme brings stability to mass spectrometry
Using the solution stable enzyme can eliminate unnecessary waste and cost. -
News Novatek International selected as partner for automation of Boehringer Ingelheim's global environmental monitoring program
NOVA-EM is Novatek's solution dedicated to managing all aspects of an automated environmental monitoring program. -
News TraceLink unveils Automated Validation Manager
Removes burden of validating software updates for Life Sciences Cloud customers. -
News New BMS collaboration to evaluate combination therapy in colorectal cancer
Phase I/II study to evaluate the combination of Opdivo (nivolumab) and Opdivo +Yervoy (ipilimumab) regimen with Mekinist (trametinib) in patients with colorectal cancer. -
News Pharmaceutical contract manufacturing/contract research market worth $238.3 billion by 2025
Expanding market for biosimilars and biobetters is anticipated to pronounce the demand for contract development and manufacturing support. -
News Lonza acquires cell and gene contract manufacturer PharmaCell
Lonza has successfully completed the acquisition of PharmaCell, a cell and gene contract manufacturer in Europe with employees in Maastricht and Geleen (NL). In 2016, PharmaCell had sales of EUR 11 million. -
News Acasti Pharma and CordenPharma announce large-scale production of CaPre with continuous manufacturing
Continuous manufacturing process will enable improved quality control and cGMP compliance, while reducing energy consumption, waste and raw material. -
News Colorcon expands in India
The new technical service laboratory is the company's 20th across the world. -
News Sartorius Stedim Biotech launches ambr 15 bioreactor system with Nova BioProfile FLEX2 integration
QbD studies in upstream processing more rapidly performed. -
News Novartis announces ground-breaking collaboration with IBM Watson Health on outcomes-based care in advanced breast cancer
Collaboration will use real-world patient data and cognitive computing with aim of improving outcomes in advanced breast cancer. -
News Extractables-free deep-well plate for uHPLC and MS applications
Porvair Glass Vial Deep-well plates are precisely manufactured to ensure complete compatibility with automated equipment. -
News Vertex reaches long-term reimbursement agreement with ROI for Orkambi, Kalydeco and future CF medicines
Agreement provides access to Orkambi for people who have two copies of the F508del mutation and expands access to Kalydeco for all eligible patients. -
News Cardinal Health Specialty Solutions publishes research-based insights on oncology
Pharmaceutical companies should play a larger role in patient support programs. -
News Hikma signs an exclusive license and supply agreement with Octapharma for Octaplex
Deal adds the first plasma-derived treatment to Hima's product offering. -
News Vetter and Microdermics to develop innovative microneedle drug delivery systems
Microdermics has successfully demonstrated the initial safety of its microneedle system, and is planning Phase I human clinical trials for vaccine and therapeutic delivery, to be initiated in 2017. -
News Cambrex invests in new capacity and continuous flow technology at its Karlskoga, Sweden facility
The expansion is part of an ongoing strategic campaign to invest in small molecule API manufacturing across the company's global network of facilities. -
News Sanner acquisition strengthens company's leadership in effervescent packaging market
Acquisition of Jaco enables Sanner to operate as a system supplier. -
News Orchard Therapeutics signs manufacturing services agreement with PCT Cell Therapy Services
Under the terms of this new agreement, PCT will provide GMP-compliant manufacturing services for Orchard’s lead product, OTL-101, an autologous ex-vivo gene therapy for the treatment of ADA-SCID.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance